NCT00001114: The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma |
|
|
| Completed | 2 | 90 | US | Interferon alfa-2b, Didanosine | National Institute of Allergy and Infectious Diseases (NIAID), Schering-Plough, Bristol-Myers Squibb | Sarcoma, Kaposi, HIV Infections | | 03/00 | | |
NCT00000954: A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma |
|
|
| Completed | 1/2 | 72 | US | Bleomycin sulfate, Vincristine sulfate, Doxorubicin hydrochloride, Zalcitabine, Didanosine | National Institute of Allergy and Infectious Diseases (NIAID), Novum, Bristol-Myers Squibb | Sarcoma, Kaposi, HIV Infections | | 09/96 | | |
